0 results for 'Amgen'
DLA Piper Exhibited 'Far From Exemplary Conduct' in Patent Infringement Case, Judge Finds
A Delaware federal judge found that the firm could keep representing a plaintiff even though it also counsels the defendant's parent company. The opinion could have broader implications for firms and attorneys representing multi-layered businesses.Litigation Department of the Year (General) Winner: Cravath, Swaine & Moore
"At every step, we place paramount focus on our clients' business needs and goals."Who Got the Work: Saul Ewing Team Appears for Samsung Bioepis in Amgen Patent Case
California-based Amgen has filed a patent infringement suit to stop Samsung Bioepis from developing bone-treatment drugs that would rival two of its top-performing products.'Monopoly Prices'?: Big Pharma Co. Amgen Accused of Anticompetitive Conduct
"A 50-mg dose of Enbrel now costs patients $7,401.83 per month: 643% more than it cost when launched in 1998," according to the allegations in the antitrust class action filed against Enbrel manufacturer Amgen Inc.In Absence of a 502(d) Order, Court Finds Waiver of Privilege
In their Federal E-Discovery column, Christopher Boehning and Daniel Toal discuss the recent decision "United States ex rel. Omni Healthcare, Inc. v. MD Spine Solutions" which "raises some interesting questions and implications for practitioners and judges dealing with privilege issues in e-discovery."View more book results for the query "Amgen"
Litigation Leaders: Don McMinn of Hollingsworth on Going Where the Work Takes You
"We have argued before federal and state courts nationwide, and we do not shy away from going toe-to-toe with plaintiffs' counsel in their preferred home-turf courthouses, whether that be suburban California or small-town Mississippi."The Real Impact of the Biden Era on M&A
"Changes in the merger review process has undoubtedly increased the cost and resource burden on merging parties," write Elizabeth Suarez, Kaylynn Moss and Terry Calvani.Lawsuits Are Flying Over Generic-Drug Disputes: Surge in Patent Litigation
Five of the suits were filed by Esperion Therapeutics, which seeks to stop competitors from selling generic versions of the company's cholesterol drug Nexletol.Trending Stories
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250
Data Management and Analytics: The Key to Success for Legal Operations
Brought to you by DiliTrust
Download Now
Small Law Firm Playbook: The Expert's Guide to Getting the Most Out of Legal Software
Brought to you by PracticePanther
Download Now
Strong & Hanni Solves Storage Woes--Learn How You Can, Too
Brought to you by Filevine
Download Now
Meeting the Requirements of California's SB 553: Workplace Violence Prevention
Brought to you by NAVEX Global
Download Now